Literature DB >> 8621548

Human p300 protein is a coactivator for the transcription factor MyoD.

W Yuan1, G Condorelli, M Caruso, A Felsani, A Giordano.   

Abstract

Human p300 protein is a cellular target of adenoviral E1A oncoprotein and a potential transcriptional coactivator. Both p300 and Rb family protein-binding regions of E1A are required for the repression of muscle gene expression, which is regulated by MyoD family transactivators. This implies that p300 is involved in MyoD-dependent transactivation. We show that the repression of MyoD-mediated E box (MyoD consensus) reporter activity by E1A is correlated with its interaction with p300, indicating that p300 participates in MyoD-dependent transactivation. In addition, p300 is able to interact both in vivo and in vitro with MyoD through a portion at the carboxyl-terminal cysteine/histidine-rich domain and associates with the components of the basal transcriptional complex through its two separate transactivation domains at the amino and carboxyl termini. Consistent with its role as a coactivator, p300 potentiates MyoD-activated transcription.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8621548     DOI: 10.1074/jbc.271.15.9009

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  110 in total

1.  Independent repressor domains in ZEB regulate muscle and T-cell differentiation.

Authors:  A A Postigo; D C Dean
Journal:  Mol Cell Biol       Date:  1999-12       Impact factor: 4.272

2.  Suppression of E1A-mediated transformation by the p50E4F transcription factor.

Authors:  E R Fernandes; R J Rooney
Journal:  Mol Cell Biol       Date:  1999-07       Impact factor: 4.272

3.  The p300/CBP acetyltransferases function as transcriptional coactivators of beta-catenin in vertebrates.

Authors:  A Hecht; K Vleminckx; M P Stemmler; F van Roy; R Kemler
Journal:  EMBO J       Date:  2000-04-17       Impact factor: 11.598

4.  Characterization of an E1A-CBP interaction defines a novel transcriptional adapter motif (TRAM) in CBP/p300.

Authors:  M J O'Connor; H Zimmermann; S Nielsen; H U Bernard; T Kouzarides
Journal:  J Virol       Date:  1999-05       Impact factor: 5.103

5.  The amino-terminal C/H1 domain of CREB binding protein mediates zta transcriptional activation of latent Epstein-Barr virus.

Authors:  D Zerby; C J Chen; E Poon; D Lee; R Shiekhattar; P M Lieberman
Journal:  Mol Cell Biol       Date:  1999-03       Impact factor: 4.272

6.  TGF-beta inhibits muscle differentiation through functional repression of myogenic transcription factors by Smad3.

Authors:  D Liu; B L Black; R Derynck
Journal:  Genes Dev       Date:  2001-11-15       Impact factor: 11.361

7.  Interaction between acetylated MyoD and the bromodomain of CBP and/or p300.

Authors:  A Polesskaya; I Naguibneva; A Duquet; E Bengal; P Robin; A Harel-Bellan
Journal:  Mol Cell Biol       Date:  2001-08       Impact factor: 4.272

8.  A calcineurin-NFATc3-dependent pathway regulates skeletal muscle differentiation and slow myosin heavy-chain expression.

Authors:  U Delling; J Tureckova; H W Lim; L J De Windt; P Rotwein; J D Molkentin
Journal:  Mol Cell Biol       Date:  2000-09       Impact factor: 4.272

9.  Down regulation of the interleukin-8 promoter by human papillomavirus type 16 E6 and E7 through effects on CREB binding protein/p300 and P/CAF.

Authors:  Shih-Min Huang; D J McCance
Journal:  J Virol       Date:  2002-09       Impact factor: 5.103

10.  Differential role of p300 and CBP acetyltransferase during myogenesis: p300 acts upstream of MyoD and Myf5.

Authors:  Jeanne-Françoise Roth; Noriko Shikama; Clea Henzen; Isabelle Desbaillets; Werner Lutz; Silvia Marino; Jonas Wittwer; Hubert Schorle; Max Gassmann; Richard Eckner
Journal:  EMBO J       Date:  2003-10-01       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.